My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
February 2017
New IDSA Guideline on Ventriculitis and Meningitis
New IDSA guidelines recommend a team approach for the successful diagnosis and treatment of complex neurological infections related to placement of devices in the brain, or as a result of neurosurgery or head trauma. The first comprehensive guidelines on healthcare-associated ventriculitis and meningitis are now available in the journal Clinical Infectious Diseases.
Federal Government Transition Updates
IDSA and HIVMA remain hard at work advocating for our strategic priorities during the federal government transition. Read about our most recent activities and how to get involved.
Journal Club
In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine. This month includes: Nephrotoxicity of Vancomycin/Piperacillin-Tazobactam Combination Therapy: Enough Smoke to Be Fire? Valganciclovir for Cytomegalovirus Prevention in Renal Transplant Patients: Low Dose vs. High Dose; Important New Data on Cardiovascular Risk in HIV-Infected Persons; Azithromycin Provides No Benefit in Acute Asthma Exacerbations; Updated Sepsis Guidelines Continue Refinement of Treatment Recommendations; Reducing Blood Culture Contamination Rates: Chlorhexidine vs. Iodine.
Upcoming dates to remember

The combined meeting of IDSA, SHEA, HIVMA, and PIDS, Oct. 4-8 in San Diego, CA. See you there!

Ensuring ID is Represented in Physician Payment Reform
Science Speaks Covers CROI
HIVMA Awards Nominations Due May 1
Members on the Move
New IDSA Guideline on Ventriculitis and Meningitis
Federal Government Transition Updates
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here